Royalty Pharma plc (RPRX)

USD 24.47

(-2.59%)

Market Cap (In USD)

10.87 Billion

Revenue (In USD)

2.35 Billion

Net Income (In USD)

1.13 Billion

Avg. Volume

2.63 Million

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
24.46-31.655
PE
-
EPS
-
Beta Value
0.466
ISIN
GB00BMVP7Y09
CUSIP
G7709Q104
CIK
1802768
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Pablo Gerardo Legorreta
Employee Count
-
Website
https://www.royaltypharma.com
Ipo Date
2020-06-16
Details
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.